Jeff Kornblau Partners for Patient Advocacy

Analysis

Jeff Kornblau Partners for Patient Advocacy is a registered charity in United States, based in Jenkintown, PA. It received its IRS tax-exemption ruling in February 2022, 4 years ago. Its declared purposes cover health care, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending June 2023, Jeff Kornblau Partners for Patient Advocacy reported income of $343k and spending of $99k, leaving 71% of income unspent that year. Across the 2 years on record, from June 2022 to June 2023, income grew from $130k to $343k (+164%), an average of +164% a year. The sharpest change came in the year to June 2023, when income rose by 164%. Over the whole period it spent 27% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Jeff Kornblau Partners for Patient Advocacy sits at the 49th percentile: it is larger than about 49% of them. Against every charity in United States with reported income it ranks in the 64th percentile, and in the 62nd percentile within PA. Charities of a similar size with the same main cause include Central New York Lyme and Tick-Borne Disease Alliance Inc ($343k), Rainbow Access Initiative Inc ($343k) and Midwest Council for Children with Disabilities ($343k).

On its Form 990 for the period ending June 2023, revenue came from contributions and grants 103% of the total. Other salaries and wages came to $64k. At year end it held assets of $339k against liabilities of $8,096, net assets of $331k. It reported 2 employees.